Lantern Pharma, Inc. (LTRN)
3.32
+0.15
(+4.73%)
USD |
NASDAQ |
May 21, 16:00
3.305
-0.02
(-0.45%)
After-Hours: 19:59
Lantern Pharma Research and Development Expense (TTM) : 9.975M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioVie, Inc. | 11.61M |
| Vertex Pharmaceuticals, Inc. | 3.891B |
| Spero Therapeutics, Inc. | 27.77M |
| Replimune Group, Inc. | 222.70M |
| Acurx Pharmaceuticals, Inc. | 1.577M |